Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: Results from a population-based study

William J. Barbaresi, Slavica K Katusic, Robert C. Colligan, Amy L. Weaver, Cynthia L. Leibson, Steven J. Jacobsen

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The purpose of this study was to offer detailed information about stimulant medication treatment provided throughout childhood to 379 children with research-identified attention-deficit hyperactivity disorder (ADHD) in the 1976-1982 Rochester, MN, birth cohort. Subjects were retrospectively followed from birth until a mean of 17.2 years of age. The complete medical record of each subject was reviewed. The history and results of each episode of stimulant treatment were compared by gender, DSMIV subtype of ADHD, and type of stimulant medication. Overall, 77.8% of subjects were treated with stimulants. Boys were 1.8 times more likely than girls to be treated. The median age at initiation (9.8 years), median duration of treatment (33.8 months), and likelihood of developing at least one side effect (22.3%) were not significantly different by gender. Overall, 73.1% of episodes of stimulant treatment were associated with a favorable response. The likelihood of a favorable response was comparable for boys and girls. Treatment was initiated earlier for children with either ADHD combined type or ADHD hyperactive-impulsive type than for children with ADHD predominantly inattentive type and duration of treatment was longer for ADHD combined type. There was no association between DSM-IV subtype and likelihood of a favorable response or of side effects. Dextroamphetamine and methylphenidate were equally likely to be associated with a favorable response, but dextroamphetamine was more likely to be associated with side effects. These results demonstrate that the effectiveness of stimulant medication treatment of ADHD provided throughout childhood is comparable to the efficacy of stimulant treatment demonstrated in clinical trials.

Original languageEnglish (US)
Pages (from-to)448-457
Number of pages10
JournalJournal of Developmental and Behavioral Pediatrics
Volume35
Issue number7
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Attention Deficit Disorder with Hyperactivity
Population
Dextroamphetamine
Therapeutics
Parturition
Methylphenidate
Diagnostic and Statistical Manual of Mental Disorders
Medical Records
History
Clinical Trials
Research

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Cite this

Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder : Results from a population-based study. / Barbaresi, William J.; Katusic, Slavica K; Colligan, Robert C.; Weaver, Amy L.; Leibson, Cynthia L.; Jacobsen, Steven J.

In: Journal of Developmental and Behavioral Pediatrics, Vol. 35, No. 7, 2014, p. 448-457.

Research output: Contribution to journalArticle

Barbaresi, William J. ; Katusic, Slavica K ; Colligan, Robert C. ; Weaver, Amy L. ; Leibson, Cynthia L. ; Jacobsen, Steven J. / Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder : Results from a population-based study. In: Journal of Developmental and Behavioral Pediatrics. 2014 ; Vol. 35, No. 7. pp. 448-457.
@article{c53620f5bf814e1cbe9bc5e390108dbe,
title = "Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: Results from a population-based study",
abstract = "The purpose of this study was to offer detailed information about stimulant medication treatment provided throughout childhood to 379 children with research-identified attention-deficit hyperactivity disorder (ADHD) in the 1976-1982 Rochester, MN, birth cohort. Subjects were retrospectively followed from birth until a mean of 17.2 years of age. The complete medical record of each subject was reviewed. The history and results of each episode of stimulant treatment were compared by gender, DSMIV subtype of ADHD, and type of stimulant medication. Overall, 77.8{\%} of subjects were treated with stimulants. Boys were 1.8 times more likely than girls to be treated. The median age at initiation (9.8 years), median duration of treatment (33.8 months), and likelihood of developing at least one side effect (22.3{\%}) were not significantly different by gender. Overall, 73.1{\%} of episodes of stimulant treatment were associated with a favorable response. The likelihood of a favorable response was comparable for boys and girls. Treatment was initiated earlier for children with either ADHD combined type or ADHD hyperactive-impulsive type than for children with ADHD predominantly inattentive type and duration of treatment was longer for ADHD combined type. There was no association between DSM-IV subtype and likelihood of a favorable response or of side effects. Dextroamphetamine and methylphenidate were equally likely to be associated with a favorable response, but dextroamphetamine was more likely to be associated with side effects. These results demonstrate that the effectiveness of stimulant medication treatment of ADHD provided throughout childhood is comparable to the efficacy of stimulant treatment demonstrated in clinical trials.",
author = "Barbaresi, {William J.} and Katusic, {Slavica K} and Colligan, {Robert C.} and Weaver, {Amy L.} and Leibson, {Cynthia L.} and Jacobsen, {Steven J.}",
year = "2014",
doi = "10.1097/DBP.0000000000000099",
language = "English (US)",
volume = "35",
pages = "448--457",
journal = "Journal of Developmental and Behavioral Pediatrics",
issn = "0196-206X",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder

T2 - Results from a population-based study

AU - Barbaresi, William J.

AU - Katusic, Slavica K

AU - Colligan, Robert C.

AU - Weaver, Amy L.

AU - Leibson, Cynthia L.

AU - Jacobsen, Steven J.

PY - 2014

Y1 - 2014

N2 - The purpose of this study was to offer detailed information about stimulant medication treatment provided throughout childhood to 379 children with research-identified attention-deficit hyperactivity disorder (ADHD) in the 1976-1982 Rochester, MN, birth cohort. Subjects were retrospectively followed from birth until a mean of 17.2 years of age. The complete medical record of each subject was reviewed. The history and results of each episode of stimulant treatment were compared by gender, DSMIV subtype of ADHD, and type of stimulant medication. Overall, 77.8% of subjects were treated with stimulants. Boys were 1.8 times more likely than girls to be treated. The median age at initiation (9.8 years), median duration of treatment (33.8 months), and likelihood of developing at least one side effect (22.3%) were not significantly different by gender. Overall, 73.1% of episodes of stimulant treatment were associated with a favorable response. The likelihood of a favorable response was comparable for boys and girls. Treatment was initiated earlier for children with either ADHD combined type or ADHD hyperactive-impulsive type than for children with ADHD predominantly inattentive type and duration of treatment was longer for ADHD combined type. There was no association between DSM-IV subtype and likelihood of a favorable response or of side effects. Dextroamphetamine and methylphenidate were equally likely to be associated with a favorable response, but dextroamphetamine was more likely to be associated with side effects. These results demonstrate that the effectiveness of stimulant medication treatment of ADHD provided throughout childhood is comparable to the efficacy of stimulant treatment demonstrated in clinical trials.

AB - The purpose of this study was to offer detailed information about stimulant medication treatment provided throughout childhood to 379 children with research-identified attention-deficit hyperactivity disorder (ADHD) in the 1976-1982 Rochester, MN, birth cohort. Subjects were retrospectively followed from birth until a mean of 17.2 years of age. The complete medical record of each subject was reviewed. The history and results of each episode of stimulant treatment were compared by gender, DSMIV subtype of ADHD, and type of stimulant medication. Overall, 77.8% of subjects were treated with stimulants. Boys were 1.8 times more likely than girls to be treated. The median age at initiation (9.8 years), median duration of treatment (33.8 months), and likelihood of developing at least one side effect (22.3%) were not significantly different by gender. Overall, 73.1% of episodes of stimulant treatment were associated with a favorable response. The likelihood of a favorable response was comparable for boys and girls. Treatment was initiated earlier for children with either ADHD combined type or ADHD hyperactive-impulsive type than for children with ADHD predominantly inattentive type and duration of treatment was longer for ADHD combined type. There was no association between DSM-IV subtype and likelihood of a favorable response or of side effects. Dextroamphetamine and methylphenidate were equally likely to be associated with a favorable response, but dextroamphetamine was more likely to be associated with side effects. These results demonstrate that the effectiveness of stimulant medication treatment of ADHD provided throughout childhood is comparable to the efficacy of stimulant treatment demonstrated in clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=84906887106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906887106&partnerID=8YFLogxK

U2 - 10.1097/DBP.0000000000000099

DO - 10.1097/DBP.0000000000000099

M3 - Article

C2 - 25180895

AN - SCOPUS:84906887106

VL - 35

SP - 448

EP - 457

JO - Journal of Developmental and Behavioral Pediatrics

JF - Journal of Developmental and Behavioral Pediatrics

SN - 0196-206X

IS - 7

ER -